Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela C Hirbe

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Current Treatment Options in Oncology|October 27, 2018
Diagnosis and Treatment of Myxoid Liposarcomas: Histology MattersSarah Abaricia, Angela C Hirbe
Neuro-Oncology|September 21, 2019
Understanding a complicated Gal-1Angela C Hirbe, David H Gutmann
The Lancet. Neurology|July 18, 2014
Neurofibromatosis type 1: a multidisciplinary approach to careAngela C Hirbe, David H Gutmann
Expert Opinion on Investigational Drugs|September 11, 2025
Mirdametinib, an FDA-Approved MEK1/2 inhibitor for adult and pediatric NF1-associated plexiform neurofibromasGorkem Oztosun, Amy Armstrong, Angela C Hirbe
Cancers|January 25, 2025
A Sequencing Overview of Malignant Peripheral Nerve Sheath Tumors: Findings and Implications for TreatmentKangwen Xiao, Kuangying Yang, Angela C Hirbe
Expert Opinion on Investigational Drugs|December 21, 2021
Plexiform neurofibroma: shedding light on the investigational agents in clinical trialsSimge Acar, Amy E Armstrong, Angela C Hirbe
Cancers|January 25, 2025
UBR5 in Tumor Biology: Exploring Mechanisms of Immune Regulation and Possible Therapeutic Implications in MPNSTDiana Akinyi Odhiambo, Selina Fan, Angela C Hirbe
The Lancet. Child & Adolescent Health|June 21, 2020
Neurofibromatosis type 1-related tumours in paediatrics: an evolving treatment landscapeAmy E Armstrong, Nicole M Brossier, Angela C Hirbe
Genes|September 5, 2020
Special Issue: "Genomics and Models of Nerve Sheath Tumors"Angela C Hirbe, Rebecca D Dodd, Christine A Pratilas
Neuro-Oncology Advances|July 10, 2020
Diagnosis and management of malignant peripheral nerve sheath tumors: Current practice and future perspectivesBethany C Prudner, Tyler Ball, Richa Rathore, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Current Treatment Options in Oncology|October 27, 2018
Diagnosis and Treatment of Myxoid Liposarcomas: Histology MattersSarah Abaricia, Angela C Hirbe
Neuro-Oncology|September 21, 2019
Understanding a complicated Gal-1Angela C Hirbe, David H Gutmann
The Lancet. Neurology|July 18, 2014
Neurofibromatosis type 1: a multidisciplinary approach to careAngela C Hirbe, David H Gutmann
Expert Opinion on Investigational Drugs|September 11, 2025
Mirdametinib, an FDA-Approved MEK1/2 inhibitor for adult and pediatric NF1-associated plexiform neurofibromasGorkem Oztosun, Amy Armstrong, Angela C Hirbe
Cancers|January 25, 2025
A Sequencing Overview of Malignant Peripheral Nerve Sheath Tumors: Findings and Implications for TreatmentKangwen Xiao, Kuangying Yang, Angela C Hirbe
Expert Opinion on Investigational Drugs|December 21, 2021
Plexiform neurofibroma: shedding light on the investigational agents in clinical trialsSimge Acar, Amy E Armstrong, Angela C Hirbe
Cancers|January 25, 2025
UBR5 in Tumor Biology: Exploring Mechanisms of Immune Regulation and Possible Therapeutic Implications in MPNSTDiana Akinyi Odhiambo, Selina Fan, Angela C Hirbe
The Lancet. Child & Adolescent Health|June 21, 2020
Neurofibromatosis type 1-related tumours in paediatrics: an evolving treatment landscapeAmy E Armstrong, Nicole M Brossier, Angela C Hirbe
Genes|September 5, 2020
Special Issue: "Genomics and Models of Nerve Sheath Tumors"Angela C Hirbe, Rebecca D Dodd, Christine A Pratilas
Neuro-Oncology Advances|July 10, 2020
Diagnosis and management of malignant peripheral nerve sheath tumors: Current practice and future perspectivesBethany C Prudner, Tyler Ball, Richa Rathore, et al.
Pageof 10